7 news items
atai Life Sciences to Participate in the Jefferies 2024 Global Healthcare Conference
ATAI
31 May 24
as a response to the significant unmet need and lack of innovation in the mental health treatment landscape. atai is dedicated to efficiently developing
atai Life Sciences Announces the Publication of Beckley Psytech's Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
ATAI
17 Apr 24
to transform the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health
Momentum Stocks Alert: DYAI, KAVL, VTAK, NKLA, ATAI Demonstrate Financial Growth and Strategic Advancements
ATAI
DYAI
KAVL
5 Apr 24
. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible
Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline
ATAI
CMPS
29 Mar 24
disorders. By pooling resources and best practices, Atai's stated aim is to responsibly accelerate the development of new medicines to achieve
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
ATAI
28 Mar 24
the treatment of mental health disorders and was founded as a response to the significant unmet need and lack of innovation in the mental health
j5gv75k9cw0xfgkfog5kj234x2ht5qdr9mg5oqfm9pzfzk4c8hqliwpkbe9
ATAI
27 Mar 24
- 55% of patients achieved a clinical response on the day after dosing and this rate of response was maintained at week 4 and week
r65lml0uwpe0y3awb0n1fme21md32vji2rkjkh
ATAI
CMND
CMPS
14 Mar 24
passed a bill to create a psychedelics task force responsible for studying possible regulatory frameworks for therapeutic access
- Prev
- 1
- Next